BioPlus Acquisition Balance Sheet Health
Financial Health criteria checks 0/6
BioPlus Acquisition has a total shareholder equity of $-16.6M and total debt of $6.6M, which brings its debt-to-equity ratio to -39.6%. Its total assets and total liabilities are $138.6M and $155.2M respectively.
Key information
-39.6%
Debt to equity ratio
US$6.57m
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.45k |
| Equity | -US$16.58m |
| Total liabilities | US$155.21m |
| Total assets | US$138.63m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIOS.U has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: BIOS.U has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOS.U has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: BIOS.U's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: BIOS.U's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if BIOS.U's interest payments on its debt are well covered by EBIT.